Skip to main content


Figure 2 | Molecular Cancer

Figure 2

From: Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential

Figure 2

Limited replicative potential of BEAC cells treated with telomerase specific SiRNAs. Barrett's associated adenocarcinoma cells SEG-1 (A) or normal cells from stomach and intestine (CRL7869) (B) were transfected with control () or telomerase specific (▲) siRNAs and cultured for four weeks. At the end of each 7-day treatment cycle, cells were harvested and the number of viable cells was determined using trypan blue exclusion.

Back to article page